Establishing secure connection…Loading editor…Preparing document…

Legal IOI Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

LEGAL IOI AGREEMENT

This Indication of Interest Agreement ("Agreement") is made effective as of by and between Party A: , an entity organized under the laws of with principal address at , and Party B: , an entity organized under the laws of with principal address at .

RECITALS

WHEREAS, Party A has expressed an interest in pursuing a potential transaction relating to (the "Target"); and

WHEREAS, Party B has provided preliminary commercial terms to Party A regarding the possible acquisition, financing, merger or other business combination involving the Target; and

WHEREAS, the parties desire to record the indicative terms, the intended process, and certain binding and non-binding obligations related to the proposed transaction.

NOW, THEREFORE, in consideration of the mutual covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:

1. NATURE OF THIS IOI

1.1. Non-Binding Statement. Except as expressly set forth in Section 1.2, this Agreement and the Indicative Terms set forth herein are non-binding and are intended solely to state the present intentions of the parties with respect to the proposed transaction. No party shall have any obligation to consummate the proposed transaction unless and until definitive transaction agreements satisfactory to the parties have been executed and delivered.

1.2. Binding Provisions. Notwithstanding Section 1.1, the parties agree that the following provisions shall be legally binding from the Effective Date: Confidentiality (Section 3), Exclusivity (Section 4) if selected, Expenses (Section 5), and Governing Law (Section 9). The parties acknowledge that injunctive relief may be sought to enforce the binding provisions.

2. INDICATIVE TERMS

2.1. Transaction Type: .

2.2. Target Entity: .

2.3. Indicative Consideration: and any contingent or earnout components as described: .

2.4. Proposed Structure and Financing:

2.5. Indicative Timeline: Initial exclusivity requested for days from Effective Date; anticipated signing date on or about and anticipated closing on or about .

3. CONFIDENTIALITY

3.1. Treatment of Information. Each party acknowledges that in the course of discussions and due diligence, it will receive Confidential Information concerning the other party or the Target. "Confidential Information" means all non-public, proprietary or commercially sensitive information disclosed in any form. Each recipient shall: (a) protect Confidential Information with at least the same degree of care it uses to protect its own confidential information, but in no event less than reasonable care; (b) not use Confidential Information for any purpose other than evaluating or pursuing the proposed transaction; and (c) not disclose Confidential Information to any third party except to its Representatives who need to know and who are bound to protect such information.

3.2. Exclusions. Confidential Information does not include information that: (a) is or becomes generally available to the public other than by breach of this Agreement; (b) is rightfully received from a third party without restriction; (c) is independently developed without use of Confidential Information; or (d) is required to be disclosed by law, provided the recipient gives prompt notice and cooperates in any attempt to limit or contest the disclosure.

3.3. Remedies. Each party acknowledges that a breach of this Section 3 would cause irreparable harm for which monetary damages would be inadequate and agrees that the disclosing party shall be entitled to equitable relief, including injunctions, without posting bond, in addition to any other remedies at law or in equity.

4. EXCLUSIVITY (NO-SHOP)

4.1. Exclusivity Selection. The parties agree that exclusivity is: .

4.2. If Exclusivity Selected. If exclusivity is selected, for the exclusivity period specified in Section 2.5 the Target shall not solicit, initiate, knowingly facilitate or engage in discussions or negotiations with any other party regarding a competing transaction, and shall promptly cease any active processes involving other potential counterparties. The parties agree that breach of this Section 4 shall entitle the non-breaching party to injunctive relief and monetary damages.

5. EXPENSES

Except as otherwise agreed in writing, each party shall bear its own expenses in connection with the preparation, negotiation and performance of this Agreement and the evaluation of the proposed transaction, including legal, accounting and advisory fees; provided, however, that if the parties thereafter enter into definitive transaction documents that provide for reimbursement of transaction expenses, the terms of such definitive documents shall govern.

6. NO BINDING OBLIGATION TO NEGOTIATE OR CLOSE

Neither party shall be under any legal obligation with respect to the proposed transaction unless and until definitive transaction agreements are executed and delivered by the parties. The parties acknowledge that they may cease discussions at any time. Nothing in this Agreement shall obligate any party to enter into any definitive agreement or to agree to any specific terms.

7. REPRESENTATIONS; AUTHORITY

Each party represents and warrants that it has full power and authority to enter into this Agreement and to perform its obligations hereunder, and that the individual executing this Agreement on its behalf is duly authorized to bind the party. Each party further represents that no consents or approvals of third parties are required for the making of this Agreement, except as disclosed in writing to the other party.

8. DUE DILIGENCE

The parties anticipate entering a period of due diligence during which Party B and its Representatives may access documents, facilities and personnel of the Target. Access granted shall be subject to the Confidentiality provisions of Section 3 and any other reasonable access protocols mutually agreed in writing. The scope and timing of due diligence shall be determined in good faith by the parties.

9. NOTICES

All notices, requests, consents and other communications hereunder shall be in writing and delivered to the addresses set forth below (or to such other address as the party may designate by notice in accordance with this Section).

10. AMENDMENT; WAIVER; SEVERABILITY; ENTIRE AGREEMENT

10.1. Amendment. This Agreement may be amended, supplemented or otherwise modified only by a written instrument executed by both parties.

10.2. Waiver. No waiver of any provision or default shall be effective unless in writing and signed by the party granting the waiver. No waiver shall constitute a waiver of any other provision or subsequent default.

10.3. Severability. If any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

10.4. Entire Agreement. This Agreement constitutes the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior and contemporaneous agreements, understandings, negotiations and discussions, whether oral or written, of the parties.

11. GOVERNING LAW; COUNTERPARTS

11.1. Governing Law. This Agreement shall be governed by and construed in accordance with the laws of , without regard to principles of conflicts of law.

11.2. Counterparts. This Agreement may be executed in two or more counterparts, each of which when executed shall be deemed an original, and all of which together shall constitute one and the same instrument. Execution and delivery by electronic means shall be valid and binding.

12. MISCELLANEOUS

12.1. Public Announcements. No party shall issue any press release or make any public announcement regarding the proposed transaction without the prior written consent of the other party, except as required by applicable law or regulatory authority, in which case the disclosing party shall use reasonable efforts to consult with the other party prior to any disclosure.

12.2. Further Assurances. Each party agrees to execute and deliver all further documents and to do all acts and things reasonably necessary to carry out the intent of this Agreement.

Party A - Printed Name:

By:

Date:

Title:

Party B - Printed Name:

By:

Date:

Title:

Enter text✕

What a Legal IOI Agreement Is and When It’s Used

A Legal IOI Agreement (Indication of Interest) is a preliminary written statement that describes a party’s intent to pursue a transaction under proposed terms. It typically outlines the proposed price or price range, key conditions, timing, and any confidentiality or exclusivity expectations. IOIs are common in mergers and acquisitions, real estate offers, and financing negotiations where parties want to document interest without committing to final, binding obligations. Certain provisions—such as confidentiality, exclusivity, or expenses—can be drafted as binding, so careful wording and legal review are important before execution.

Why a Clear IOI Matters for Transaction Efficiency

A well‑drafted Legal IOI Agreement clarifies initial commercial terms, reduces negotiation cycles, and protects sensitive information through confidentiality. It provides a roadmap for due diligence and timing while reserving final contractual commitments for subsequent definitive agreements.

Why a Clear IOI Matters for Transaction Efficiency

Who Typically Prepares and Signs an IOI

Parties use IOIs to establish early alignment and record the scope of proposed negotiations.

  • Buyers and investors seeking to outline price range and due diligence timelines before drafting definitive documents.
  • Sellers or owners providing market signals and setting exclusivity or confidentiality expectations during negotiation periods.
  • Advisors and legal counsel who draft standard language, confirm signatory authority, and manage conditional clauses.

Use the IOI to reduce ambiguity, then convert negotiated terms into a binding purchase agreement or contract when ready.

Key Signatory Roles and Typical Representatives

Buyer Representative

A corporate development or investment professional who signs to record preliminary terms and authorize due diligence. They should state purchasing entity name, authorized signer title, and any financing contingencies to avoid later disputes.

Seller Representative

An owner, CEO, or designated broker who provides property details or business disclosures and signs to accept negotiation parameters. Include corporate capacity and any limitation on the ability to bind the company.

Essential Data Elements to Include

Party Names: Full legal names
Addresses: Street, city, state, ZIP
Price Range: Specific dollar range
Effective Date: MM/DD/YYYY
Confidentiality: NDA reference
Signatory Authority: Title and capacity

Step-by-Step: Completing a Legal IOI Agreement

Follow these key steps to prepare a clear, enforceable IOI Agreement and transition to a definitive contract.

  • 01
    Prepare Draft: Assemble proposed price, scope, and basic conditions for review.
  • 02
    Confirm Parties: Enter full legal names and authorized signers with titles.
  • 03
    Set Timeline: Specify due diligence window, exclusivity, and any response deadlines.
  • 04
    Sign & Distribute: Execute, retain copies, and circulate to advisors and lenders.

Typical Online Workflow Settings for an IOI

Configure your digital workflow to match the document’s required signer order and authentication level.

Field Configuration
Signer Order Sequential | Signers complete in order
Authentication Email plus optional SMS code
Reminders Automated reminders every 48 hours
Audit Trail Enable IP, timestamp, and action log

Digital Signing and File Requirements

Use a secure eSignature platform that supports common file types, audit trails, and signer authentication for legal IOIs.

  • File Formats: PDF or DOCX preferred
  • Integrations: Salesforce, NetSuite, Microsoft 365
  • Security Standards: TLS in transit; AES‑256 at rest

Confirm the chosen platform meets required compliance (ESIGN, UETA) and any industry rules such as HIPAA; enable audit logs and secure storage.

How Online Execution Typically Works

A typical online signing flow maps to upload, field placement, signer authentication, and completion with an audit trail.

  • Upload Document: Sender uploads the IOI in PDF or DOCX format.
  • Place Fields: Add signature, date, and initials where required.
  • Authenticate: Signer verifies identity via email, SMS, or KBA.
  • Complete: Signed copies and the audit trail are retained.

Common Deadlines and Timing Considerations

IOIs often create specific response and diligence timelines; set and track these dates to avoid disputes or missed opportunities.

Response Window:

Typical 7–14 days to accept or counteroffer.

Exclusivity Period:

Commonly 30–90 days during due diligence.

Due Diligence:

Usually 30–60 days depending on scope.

Target Closing Date:

Specify a provisional closing date when known.

Termination Notice:

Provide required notice period for termination.

Key Transaction Milestones from IOI to Closing

Sequential milestones clarify progress and responsibilities from initial interest through final agreement and closing.

01

IOI Issued

Parties document initial terms and intent to negotiate.

02

Due Diligence

Buyer reviews financials, contracts, and operations.

03

Definitive Agreement

Negotiate and sign the binding purchase agreement.

04

Closing

Complete transfers, payments, and post‑closing obligations.

Core Sections to Include in a Professional IOI

Ensure the IOI contains clear sections that separate nonbinding business terms from any intended binding provisions.

Purpose Statement

Explain the IOI’s role as a preliminary expression of interest and explicitly state whether the document is intended to be nonbinding except where noted.

Price or Range

Set out the proposed purchase price or price range, currency, and any allocation assumptions so parties share a common baseline for negotiations.

Key Conditions

Identify material conditions such as financing, regulatory approvals, title review, or third‑party consents that must be satisfied for a transaction to proceed.

Confidentiality

Reference an executed NDA or include confidentiality obligations, specifying the scope of information covered and permitted disclosures.

Exclusivity

If applicable, describe any exclusive negotiation period, its duration, permitted activities, and remedies for breach of exclusivity.

Signatures

Provide signature blocks with printed names, titles, entity names, and execution dates; require authorized signatories to avoid later challenges.

Risks and Potential Consequences of Errors

Misstated Terms: Ambiguity leads to disputes
Lack of Authority: Unauthorized signer can void agreement
Invalid Signature: Improperly authenticated signatures may be challenged
Confidentiality Breach: Unprotected disclosures risk liability
Missed Deadlines: Can forfeit negotiation or exclusivity rights
Tax Issues: Incorrect statements may trigger tax review

Common Preparation Mistakes to Avoid

  • Using vague or open‑ended pricing language that leaves essential terms undefined and invites interpretation disputes during negotiation.
  • Failing to confirm signatory authority or entity formation details, which can require post‑execution cures and delay closing.
  • Mixing binding and nonbinding language in the same paragraph without clear labels, producing unintended legal obligations.
  • Neglecting to attach required exhibits or schedules (financial statements, asset lists), which impedes due diligence and can void provisions.

How an IOI Differs from Related Documents

Compare short preliminary documents to help choose the right instrument for each negotiation stage.

Document Type | Binding? | Typical Use IOI Usually nonbinding Early market testing
Letter of Intent | Binding? | Typical Use loi sometimes binding detailed negotiation roadmap
Term Sheet | Binding? | Typical Use term sheet generally nonbinding key commercial terms
Purchase Agreement | Binding? | Typical Use purchase agreement binding final transfer terms
NDA | Binding? | Typical Use nda binding protect confidential disclosures

Representative eSignature Pricing for Completing a Legal IOI

Choose an eSignature provider that meets your security and compliance needs; pricing models vary by user, volume, and plan features.

signNow DocuSign Adobe Sign PandaDoc HelloSign
Starting Price $8/user/mo $15/user/mo $14/user/mo $19/user/mo $15/user/mo
Free Trial 7-day free trial No No Yes, limited Yes, limited
Bulk Send Yes Yes Yes Yes No
Audit Trail Yes Yes Yes Yes Yes
HIPAA Compliant Yes Yes Yes No No

Real-World Examples of Document Use

These real customer examples illustrate how teams use digital execution to speed transaction workflows and maintain compliance.

Optica Ventures — COO

Optica used IOIs to prequalify deal interest and coordinate buyers quickly

  • Simplicity aided counterparties’ response rates
  • The interface was easy for internal teams and customers, enabling faster follow‑up and clearer next steps during due diligence while preserving confidentiality.

Martin Properties — Founder

A real estate owner used IOIs for multiple property offers

  • Mobile signing improved speed
  • Processing and executing documents online provided consistent compliance and security, allowing transactions to move without in‑person meetings and reducing time to contract execution.

Frequently Asked Questions and Practical Answers

Answers to common legal and practical questions about creating, executing, and enforcing a Legal IOI Agreement.


Need help? Contact support

be ready to get more
Join over 28 million airSlate SignNow users